CVRx (CVRX) Net Income towards Common Stockholders (2020 - 2026)

CVRx (CVRX) recorded quarterly Net Income towards Common Stockholders of -$13.1 million in Q1 2026, down 9.77% quarter-over-quarter from -$12.0 million in Q4 2025, and up 4.69% on a YoY basis from -$12.5 million in Q1 2025.

CVRx (CVRX) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

CVRx's Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$13.1 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 4.69% year-over-year to -$13.1 million; the TTM figure through Mar 2026 stood at -$52.7 million (down 2.2% YoY), while the FY2025 annual figure was -$53.3 million, up 11.07% from the prior year.
  • Net Income towards Common Stockholders was -$13.1 million for Q1 2026 at CVRx, down from -$12.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$9.0 million in Q3 2023 to a low of -$22.2 million in Q1 2024.
  • Historically, Net Income towards Common Stockholders has averaged -$12.3 million across 5 years, with a median of -$11.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders plunged 95.06% in 2024, then soared 37.95% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$10.5 million in 2022, then rose by 14.43% to -$9.0 million in 2023, then retreated by 18.13% to -$10.7 million in 2024, then slipped by 12.21% to -$12.0 million in 2025, then declined by 9.77% to -$13.1 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$13.1 million (Q1 2026), -$12.0 million (Q4 2025), and -$12.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 CVRx 132.04 Mn 59.74 Mn 12.88 Mn -13.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.12 Mn
Dec 31, 2025 -11.95 Mn
Sep 30, 2025 -12.87 Mn
Jun 30, 2025 -14.74 Mn
Mar 31, 2025 -13.77 Mn
Dec 31, 2024 -10.65 Mn
Sep 30, 2024 -13.10 Mn
Jun 30, 2024 -14.03 Mn
Mar 31, 2024 -22.19 Mn
Dec 31, 2023 -9.02 Mn
Sep 30, 2023 -9.01 Mn
Jun 30, 2023 -11.65 Mn
Mar 31, 2023 -11.37 Mn
Dec 31, 2022 -10.54 Mn
Sep 30, 2022 -9.83 Mn
Jun 30, 2022 -11.07 Mn
Mar 31, 2022 -9.99 Mn
Dec 31, 2021 -10.57 Mn
Sep 30, 2021 -6.13 Mn
Jun 30, 2021 -17.75 Mn